LOADING ACTIVE HISTORY HOME Active Inside Active History Founded by Innate Pharma and Transgene in 2011, our company is a leader in soluble and cellular biomarker analysis in the context of clinical trials. We offer expert services to advance innovative therapies from pre-clinical to clinical testing. In 2014, Platine Pharma services was acquired by ABL Inc, a global contract manufacturing and laboratory research service provider, a full subsidiary of Institut Mérieux. In 2020, alongside its senior managers, Turenne Santé acquired our company, creating a new entity named Active Biomarkers. Active Biomarkers' team has decades of experience in immunological-based assays. We develop tailored assays to support human clinical trials and pre-clinical animal studies. Our everyday mission is to design and run bioanalyses to help our clients better understand the impact of their cutting-edge therapies, document the mechanisms of action, correlates of protection, pharmacokinetic/pharmacodynamic, and other critical safety and efficacy data. Since 2011, Active Biomarkers is accredited for French research tax credit (CIR). Name Company Name Email Phone Subject Subject Contact us Request for a quote Other Message Subscribe to the newsletter Send Message Contact us ADDRESS Active Biomarkers 60 F Avenue Rockefeller BIOSERRA 2 Building 3rd floor 69008 Lyon France SOCIAL Copyright © 2020 Active Biomarkers - Privacy Notice Created by OMORIN WEB

LOADING MANAGEMENT HOME Active Inside The Active Team Management Marc Essodaigui GENERAL MANAGER Christine Bain SCIENTIFIC DIRECTOR Cendrine Josson DIRECTOR OF OPERATIONS Magali Roche PH.D., SALES & MARKETING DIRECTOR Isabelle Valerino-Corler QUALITY DIRECTOR Laure Veron DIRECTOR OF LABORATORY AND QUALITY CONTROL Name Company Name Email Phone Subject Subject Contact us Request for a quote Other Message Subscribe to the newsletter Send Message Contact us ADDRESS Active Biomarkers 60 F Avenue Rockefeller BIOSERRA 2 Building 3rd floor 69008 Lyon France SOCIAL Copyright © 2020 Active Biomarkers - Privacy Notice Created by OMORIN WEB

LOADING ANTI-DRUG ANTIBODY DETECTION HOME ACTIVE SOLUTIONS Active Services Anti-Drug Antibody Detection Biologics, such as antibodies, are potentially immunogenic and may elicit anti-drug antibodies (so-called ADAs). In addition to harmful clinical manifestations such as allergy or inflammation burst, ADAs may impact the PK-PD characteristics, contributing to clearance or biological inactivation (neutralizing antibodies) of biotherapeutic agents. At Active Biomarkers, we can evaluate ADAs on multiple platforms (Gyrolab XPlore™, MSD SQ120, conventional ELISA) according to the multi-tiered approach recommended by the regulatory guidelines. Name Company Name Email Phone Subject Subject Contact us Request for a quote Other Message Subscribe to the newsletter Send Message Contact us ADDRESS Active Biomarkers 60 F Avenue Rockefeller BIOSERRA 2 Building 3rd floor 69008 Lyon France SOCIAL Copyright © 2020 Active Biomarkers - Privacy Notice Created by OMORIN WEB